Skip to content

Investigation of the results of the WALANT and single-injection nerve block

Comparison of the Results of the WALANT Method with Single-injection Nerve Block in Patients Requiring Digital Anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230410057871N6
Enrollment
64
Registered
2025-01-01
Start date
2023-07-23
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand surgery.

Interventions

Intervention 1: Intervention group: In the WALANT group, we will use the WALANT cocktail consisting of 50 ml of normal saline, 50 ml of 2% lidocaine, 1 ml of epinephrine (1:1000), and 10 ml of 8.4% so

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients requiring hand surgery at Shohada-ye Ashayer Teaching Hospital in Khorramabad Age 18 years and older

Exclusion criteria

Exclusion criteria: Subjects with a history of previous surgery on the ipsilateral hand

Design outcomes

Primary

MeasureTime frame
Change in the pain reported by the patient (pain measured by the Visual Analogue Scale). Timepoint: The pain level will be recorded patient at 1, 3, 5, 15, and 20 minutes. Method of measurement: The patient's pain after the injection is measured with a ruler that ranges from 0 to 10 cm so that 0 is the sign of no pain and 10 is the most severe pain ever experienced.

Secondary

MeasureTime frame
Analgesia onset time in patients in the two groups. Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: The level of pain will be recorded at 1, 3, 5, 15, and 20 minutes.;Incidence of arterial blood oxygen saturation below 90% for more than 60 seconds. Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: Arterial blood oxygen saturation will be measured by a pulse oximeter from the first finger of the right or left hand. Any drop below 90% for more than 60 seconds will be considered positive.;Change in pulse rate. Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: The pulse rate will be measured by a pulse oximeter from the first finger of the right or left hand.;Change in blood pressure (increase or decrease),. Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: Blood pressure will be checked using vital signs monitor.;Change in respiratory rate (increase or decrease(. Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: Respiratory rate will be checked using vital signs monitor.;Rate of side effects (nausea and vomiting or loss of consciousness). Timepoint: Minutes 1, 3, 5, 15 and 20. Method of measurement: Patients will be examined and asked about experiencing side effects.;Overall satisfaction of patients 60 minutes after the end of receiving the medication. Timepoint: Minute 60. Method of measurement: Overall satisfaction will be evaluated based on a 5-point scale (0=poor, 1=moderate, 2=good, 3=very good, 4=excellent) within 60 minutes after receiving the medication.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArian Karimi Rouzbahani

Khoram-Abad University of Medical Sciences

arian.karimi@sbmu.ac.ir+98 930 675 7977

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026